HSBC Holdings’s Foghorn Therapeutics FHTX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-18,709
| Closed | -$66.6K | – | 2594 |
|
2025
Q1 | $66.6K | Sell |
18,709
-19
| -0.1% | -$68 | ﹤0.01% | 2418 |
|
2024
Q4 | $88.2K | Buy |
18,728
+2,061
| +12% | +$9.71K | ﹤0.01% | 2484 |
|
2024
Q3 | $158K | Buy |
16,667
+798
| +5% | +$7.55K | ﹤0.01% | 2316 |
|
2024
Q2 | $89.2K | Buy |
15,869
+78
| +0.5% | +$438 | ﹤0.01% | 2382 |
|
2024
Q1 | $106K | Buy |
15,791
+2,203
| +16% | +$14.8K | ﹤0.01% | 2417 |
|
2023
Q4 | $90.5K | Buy |
13,588
+16
| +0.1% | +$107 | ﹤0.01% | 2136 |
|
2023
Q3 | $70.7K | Hold |
13,572
| – | – | ﹤0.01% | 2090 |
|
2023
Q2 | $98.8K | Hold |
13,572
| – | – | ﹤0.01% | 1992 |
|
2023
Q1 | $83.3K | Hold |
13,572
| – | – | ﹤0.01% | 2094 |
|
2022
Q4 | $84.3K | Buy |
13,572
+2,972
| +28% | +$18.5K | ﹤0.01% | 2442 |
|
2022
Q3 | $92K | Hold |
10,600
| – | – | ﹤0.01% | 2310 |
|
2022
Q2 | $148K | Hold |
10,600
| – | – | ﹤0.01% | 2527 |
|
2022
Q1 | $163K | Sell |
10,600
-1,136
| -10% | -$17.5K | ﹤0.01% | 2655 |
|
2021
Q4 | $267K | Sell |
11,736
-9,056
| -44% | -$206K | ﹤0.01% | 2384 |
|
2021
Q3 | $284K | Hold |
20,792
| – | – | ﹤0.01% | 2123 |
|
2021
Q2 | $219K | Buy |
20,792
+2,050
| +11% | +$21.6K | ﹤0.01% | 2283 |
|
2021
Q1 | $251K | Sell |
18,742
-158
| -0.8% | -$2.12K | ﹤0.01% | 2059 |
|
2020
Q4 | $385K | Buy |
+18,900
| New | +$385K | ﹤0.01% | 1969 |
|